• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B细胞非霍奇金淋巴瘤的免疫表型变异性:一项通过流式细胞术分析病例的回顾性研究。

Immunophenotypic variability of B-cell non-Hodgkin lymphoma: a retrospective study of cases analyzed by flow cytometry.

作者信息

Echeverri Carolina, Fisher Stephen, King David, Craig Fiona E

机构信息

Department of Pathology, University of Texas Health Science Center, San Antonio, USA.

出版信息

Am J Clin Pathol. 2002 Apr;117(4):615-20. doi: 10.1309/AAYH-1FK8-38PL-Q6DT.

DOI:10.1309/AAYH-1FK8-38PL-Q6DT
PMID:11939737
Abstract

Flow cytometric analysis is important in the diagnosis, classification, and follow-up of non-Hodgkin lymphoma. It is assumed that the lymphoma phenotype for each patient remains unchanged over time and is consistent from one specimen to another. To determine the variability in expression of lymphoid antigens, we reviewed 211 flow cytometry specimens of malignant lymphoma from 81 patients. Some antigens showed a stable pattern of expression such as CD5, CD10, CD19, CD20, and HLA-DR. In contrast, CD21, CD22, CD23, and CD25 showed more variability from one specimen to another. We believe several factors affect the stability of antigen expression. True differences in expression most probably are related to the biology and function of the different antigens. For instance, CD19 and CD20 are essential in cell maturation and function and, therefore, are present on the majority of cells. In contrast, CD22 has a role during B-cell activation and, therefore, is more variable. Lack of standardization inflow cytometry procedures also is responsible for some variability. Instrument settings for adequate compensation and the criteria used to determine when an antigen is reported as positive are important considerations when evaluating flow cytometry histograms.

摘要

流式细胞术分析在非霍奇金淋巴瘤的诊断、分类及随访中具有重要意义。一般认为,每位患者的淋巴瘤表型随时间保持不变,且在不同标本间具有一致性。为确定淋巴样抗原表达的变异性,我们回顾了来自81例患者的211份恶性淋巴瘤流式细胞术标本。一些抗原呈现出稳定的表达模式,如CD5、CD10、CD19、CD20和HLA-DR。相比之下,CD21、CD22、CD23和CD25在不同标本间的变异性更大。我们认为有几个因素会影响抗原表达的稳定性。表达上的真正差异很可能与不同抗原的生物学特性和功能有关。例如,CD19和CD20在细胞成熟和功能中至关重要,因此存在于大多数细胞上。相比之下,CD22在B细胞激活过程中发挥作用,因此变异性更大。流式细胞术操作缺乏标准化也导致了一些变异性。在评估流式细胞术直方图时,用于适当补偿的仪器设置以及确定抗原何时报告为阳性的标准是重要的考虑因素。

相似文献

1
Immunophenotypic variability of B-cell non-Hodgkin lymphoma: a retrospective study of cases analyzed by flow cytometry.B细胞非霍奇金淋巴瘤的免疫表型变异性:一项通过流式细胞术分析病例的回顾性研究。
Am J Clin Pathol. 2002 Apr;117(4):615-20. doi: 10.1309/AAYH-1FK8-38PL-Q6DT.
2
Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.对取自不同解剖部位的样本中,非霍奇金B细胞淋巴瘤抗原表达模式进行流式细胞术免疫表型分析。
Ann N Y Acad Sci. 2004 Dec;1028:457-62. doi: 10.1196/annals.1322.054.
3
Concomitant delineation of surface Ig, B-cell differentiation antigens, and HLADR on lymphoid proliferations using three-color immunocytometry.使用三色免疫细胞分析法对淋巴增殖物上的表面免疫球蛋白、B细胞分化抗原和人类白细胞抗原DR进行同步描绘。
Cytometry. 1991;12(4):350-9. doi: 10.1002/cyto.990120410.
4
[Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].112例淋巴系统恶性疾病的骨髓免疫表型分析
Ai Zheng. 2007 Apr;26(4):418-22.
5
Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.治疗后B细胞慢性淋巴细胞白血病细胞的抗原调节及定量流式细胞术检测
Neoplasma. 2004;51(2):97-102.
6
Simultaneous expression of CD13, CD22 and CD25 is related to the expression of Fc epsilon R1 in non-lymphoid leukemia.CD13、CD22和CD25的同时表达与非淋巴细胞白血病中FcεR1的表达相关。
Leuk Res. 2004 Jul;28(7):691-8. doi: 10.1016/j.leukres.2003.10.034.
7
Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.毛细胞白血病患者外周血和骨髓细胞的流式细胞术:毛细胞的表型、淋巴细胞亚群及治疗后微小残留病的检测
Neoplasma. 2001;48(5):350-7.
8
Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.使用分化群抗体微阵列对白血病进行免疫表型分析。
Cancer Res. 2001 Jun 1;61(11):4483-9.
9
Human hematopoietic cell lines: a model system for study of minimal residual disease detection technique in acute leukemia.人造血细胞系:急性白血病微小残留病检测技术研究的模型系统。
Neoplasma. 1995;42(5):227-34.
10
Immunophenotypic profile of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia.淋巴浆细胞淋巴瘤/华氏巨球蛋白血症的免疫表型特征
Am J Clin Pathol. 2005 Sep;124(3):414-20. doi: 10.1309/3G1X-DX0D-VHBN-VKB4.

引用本文的文献

1
Novel and multiple targets for chimeric antigen receptor-based therapies in lymphoma.淋巴瘤中基于嵌合抗原受体疗法的新型多靶点
Front Oncol. 2024 Apr 22;14:1396395. doi: 10.3389/fonc.2024.1396395. eCollection 2024.
2
Genomic crossroads between non-Hodgkin's lymphoma and common variable immunodeficiency.非霍奇金淋巴瘤与普通变异性免疫缺陷之间的基因组交叉路口。
Front Immunol. 2022 Aug 5;13:937872. doi: 10.3389/fimmu.2022.937872. eCollection 2022.
3
Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphoma.
抗原表达强度反映了慢性淋巴细胞白血病、单克隆 B 细胞淋巴增生症和小淋巴细胞淋巴瘤中的 IGHV 突变状态和多纳定义的预后类别。
Leuk Lymphoma. 2021 Aug;62(8):1828-1839. doi: 10.1080/10428194.2021.1894641. Epub 2021 Mar 18.
4
Bone marrow aspirate and biopsy: a pathologist's perspective. II. interpretation of the bone marrow aspirate and biopsy.骨髓穿刺和活检:病理学家的视角。二、骨髓穿刺和活检的解读。
J Clin Lab Anal. 2009;23(5):259-307. doi: 10.1002/jcla.20305.
5
Role of immunohistochemistry in staging diffuse large B-cell lymphoma (DLBCL).免疫组织化学在弥漫性大B细胞淋巴瘤(DLBCL)分期中的作用。
J Histochem Cytochem. 2008 Oct;56(10):893-900. doi: 10.1369/jhc.2008.951087. Epub 2008 Jun 23.
6
High CD21 expression inhibits internalization of anti-CD19 antibodies and cytotoxicity of an anti-CD19-drug conjugate.高CD21表达抑制抗CD19抗体的内化以及抗CD19-药物偶联物的细胞毒性。
Br J Haematol. 2008 Jan;140(1):46-58. doi: 10.1111/j.1365-2141.2007.06883.x. Epub 2007 Nov 7.
7
CD20 positive T cell lymphoma: is it a real entity?CD20 阳性 T 细胞淋巴瘤:它是一种真实存在的实体吗?
J Clin Pathol. 2004 Apr;57(4):442-4. doi: 10.1136/jcp.2003.011734.